CreditReports.dk
HomeScreen companies

MISSIONPHARMA A/S Financials, key figures and credit report

CVR number: 26902398 Established 2002 Industry: 46 Wholesale trade
Company contact details
Vassingerødvej 9, 3540 Lynge info@missionpharma.com tel: 48163248
Net sales 934.5 mDKK FY 2025 +25.9% vs 2024
EBIT margin 16.5 % FY 2025 +4.6 pp vs 2024
Net debt -25.1 mDKK FY 2025 -288.1% vs 2024
Quick ratio 3.9 FY 2025 -0.4 vs 2024

Income statement (mDKK)

2022
2023
2024
2025
Fiscal period length12121212
Net sales942.49940.12741.96934.47
Costs of manufacturing- 592.48- 560.02- 482.87- 535.38
External services- 135.08- 176.51- 111.08- 178.39
Gross profit214.93203.59148.01220.70
Employee benefit expenses-56.41-56.97-56.91-62.45
Other operating expenses-0.75-1.38-1.78-1.90
Total depreciation-1.55-1.42-1.36-2.49
EBIT156.22143.8287.95153.85
Other financial income1.985.5918.3127.48
Other financial expenses-6.12-2.77-17.21-34.40
Net income from associates (fin.)1.725.524.075.65
Pre-tax profit153.79152.1793.12152.59
Income taxes-33.78-32.30-19.71-32.38
Net earnings120.01119.8673.40120.20

Assets (mDKK)

2022
2023
2024
2025
Development expenditure1.2912.5611.45
Intangible assets total1.2912.5611.45
Land and waters21.3020.3419.4118.48
Buildings1.581.841.451.21
Tangible assets total22.8822.1820.8619.68
Holdings in group member companies36.4634.3137.3036.61
Other non-current investments36.46
Investments total72.9134.3137.3036.61
Non-current loans receivable-36.02
Long term receivables total-36.02
Finished products/goods37.8045.5434.6947.08
Inventories total37.8045.5434.6947.08
Current trade debtors42.3637.6360.1527.15
Current amounts owed by group member comp.330.45275.91185.16234.16
Prepayments and accrued income58.159.2424.7644.38
Current other receivables2.944.931.281.93
Current deferred tax assets12.1919.6317.1910.09
Short term receivables total446.11347.35288.54317.72
Cash and bank deposits11.2219.719.2632.34
Cash and cash equivalents11.2219.719.2632.34
Balance sheet total (assets)554.90470.38403.20464.88

Equity and liabilities (mDKK)

2022
2023
2024
2025
Share capital2.102.102.102.10
Asset revaluation reserve12.5611.45
Shares repurchased150.00119.0073.00120.00
Other reserves34.2435.1038.1737.06
Retained earnings43.3743.2573.9026.93
Profit of the financial year120.01119.8673.40120.20
Shareholders equity total349.72319.32273.13317.75
Provisions7.629.7512.0720.60
Non-current other liabilities7.629.7512.0720.60
Non-current liabilities total7.629.7512.0720.60
Advances received104.2876.3748.4236.45
Current trade creditors55.3827.1248.3357.69
Current owed to group member9.077.092.787.20
Other non-interest bearing current liabilities28.8330.7418.4625.18
Current liabilities total197.56141.32118.00126.53
Balance sheet total (liabilities)562.52480.13415.28485.48
Page generated